StockData
IRIDEX Corp logo

IRIDEX Corp (IRIX) income statement

IRIXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends January 3
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Oct 3, 2026Last filing: 10-Q on Nov 17, 2026Score 8/30
$0.50−0.20 (-28.53%)

Close on Nov 18, 2026Market cap $8.78MP/E –Yield –

IRIDEX Corp income statement

Ratios

Latest available, balances at Oct 3, 2026

Profitability, TTM

Gross margin
38.2%
Operating margin
-5.1%
Net margin
-6.9%
Return on equity, FY2025
-126.4%

Financial strength

Current ratio
1.76
Debt to equity
–
Debt to assets
–
Cash to current liabilities
28.3%

Valuation

P/E ratio
–
Price to sales
0.18
Price to book
3.34
Dividend yield
–

See a number that looks wrong?